Below are articles from various sources about members of MCB and their research.
Read the recent Wall Street Journal article featuring Dr. Jennifer Doudna's Crispr-CAS9 research, Why Gene-Editing Technology Has Scientists Excited: Researchers explore the idea of treating disease by replacing defective genes.
Assistant Professor of Neurobiology Stephan Lammel was awarded the 2015 Regents' Junior Faculty Fellowship which is a competitive award on campus. It provides summer salary awards to junior faculty, allowing them to devote their time exclusively to research, independent study, or improving their teaching effectiveness.
Professor of Biochemistry, Biophysics and Structural Biology Jennifer Doudna has been honored with the 2015 Gruber Genetics Prize along with her CrisprCAS9 collaborator, Emmanuelle Charpentier. The International Prize Program honors individuals whose groundbreaking work provides new models that inspire and enable fundamental shifts in knowledge and culture.
This summer brings change to MCB -- the Co-Chairs thank past division heads for their service and announce some new division, committee, and program heads.
Two scientists in Molecular and Cell Biology -- Assistant Professor of Cell and Developmental Biology Polina Lishko and Postdoctoral Researcher Juan-Pablo Castillo -- have been selected as this year’s Pew scholars, a program for investigators of outstanding promise in science relevant to the advancement of human health.
Professors Jennifer Doudna and Emmanuelle Charpentier have been awarded the Princess of Asturias Award for their gene editing technology. The Asturias Award for Technical and Scientific Research is given to those whose research findings and/or inventions represent an outstanding contribution to the progress and welfare of humanity.
Associate Professors of Biochemistry, Biophysics and Structural Biology Britt Glaunsinger and Andreas Martin have been named as Howard Hughes Medical Institute (HHMI) Investigators. HHMI investigators are considered to be among the nation’s top biomedical researchers and receive flexible financial support, including salary and research funding.